Minovia Therapeutics Ltd.

7 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS (NCT06465160)	Minovia Therapeutics Ltd.	2024-05-27
Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers (NCT06474104)	Minovia Therapeutics Ltd.	2024-05-12
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS) (NCT06017869)	Minovia Therapeutics Ltd.	2023-07-31
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome (NCT06144515)	Minovia Therapeutics Ltd.	2023-02-09
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion (NCT04548843)	Minovia Therapeutics Ltd.	2022-03-01
A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome (NCT03384420)	Minovia Therapeutics Ltd.	2019-02-13
Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies (NCT03762512)	Minovia Therapeutics Ltd.	2018-12-01

Every clearance here is in the API, with alerts when new ones post.